Beneath the Fatty Liver: Screening for Bone, Muscle and Vitamin D Deficits and Risk-Tailored Rehabilitation in Young and Middle-Aged Patients with MASLD

M. B. Temirova *

Department of Internal Diseases, Endocrinology, Tashkent State Medical University, Tashkent, Uzbekistan.

A. A. Khamrayev

Department of Internal Diseases, Endocrinology, Tashkent State Medical University, Tashkent, Uzbekistan.

G. N. Sobirova

Department of Medical Rehabilitation, Neurology, and Sports Medicine, Tashkent State Medical University, Tashkent, Uzbekistan.

*Author to whom correspondence should be addressed.


Abstract

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) in younger and middle-aged adults may coexist with abnormalities in bone mineral density, muscle mass and vitamin D status that are not routinely assessed.

Objective: To examine these abnormalities and evaluate risk-tailored rehabilitation alongside standard treatment.

Methods: In this prospective, controlled, parallel-group study, 111 participants were assessed: 91 patients aged 18–59 years with MASLD and 20 healthy controls. Patients received standard treatment (group I; n = 47) or standard treatment with a risk-tailored rehabilitation programme (group II; n = 44), with assessments over 12 months. Dual-energy X-ray absorptiometry, serum 25(OH)D, metabolic indices and liver measurements were used.

Results: Reduced bone mineral density and vitamin D deficiency were each identified in 53.8% of patients, and low muscle mass in 24.2%. Lower vitamin D status was associated with less favourable bone, metabolic and hepatic indices. At 12 months, body weight decreased by 3.1% in group I and 7.3% in group II, CAP by 7.9% and 18.6%, and HOMA-IR by 20.9% and 44.4%, respectively. Serum 25(OH)D increased from 19.4 to 22.1 ng/mL in group I and from 18.9 to 34.6 ng/mL in group II. L1–L4 bone mineral density changed by −1.3% and +1.5%, respectively, without statistically significant within-group changes.

Conclusion: The findings support further evaluation of integrated musculoskeletal screening and risk-tailored rehabilitation in MASLD.

Keywords: MASLD, vitamin D deficiency, bone mineral density, sarcopenia, DXA, risk stratification, rehabilitation, young and middle-aged adults


How to Cite

Temirova, M. B., A. A. Khamrayev, and G. N. Sobirova. 2026. “Beneath the Fatty Liver: Screening for Bone, Muscle and Vitamin D Deficits and Risk-Tailored Rehabilitation in Young and Middle-Aged Patients With MASLD”. Asian Journal of Medicine and Health 24 (12):10-17. https://doi.org/10.9734/ajmah/2026/v24i121475.

Downloads

Download data is not yet available.